Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies
To investigate the relations between caffeine-derived metabolites (methylxanthines) and plasma lipids by use of population-based data from 2 European countries. Families were randomly selected from the general population of northern Belgium (FLEMENGHO), from August 12, 1985, until November 22, 1990,...
Gespeichert in:
Veröffentlicht in: | Mayo Clinic proceedings 2021-12, Vol.96 (12), p.3071-3085 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3085 |
---|---|
container_issue | 12 |
container_start_page | 3071 |
container_title | Mayo Clinic proceedings |
container_volume | 96 |
creator | Petrovic, Dusan Pruijm, Menno Ponte, Belén Dhayat, Nasser A. Ackermann, Daniel Ehret, Georg Ansermot, Nicolas Vogt, Bruno Martin, Pierre-Yves Stringhini, Silvia Estoppey-Younès, Sandrine Thijs, Lutgarde Zhang, Zhenyu Melgarejo, Jesus D. Eap, Chin B. Staessen, Jan A. Bochud, Murielle Guessous, Idris |
description | To investigate the relations between caffeine-derived metabolites (methylxanthines) and plasma lipids by use of population-based data from 2 European countries.
Families were randomly selected from the general population of northern Belgium (FLEMENGHO), from August 12, 1985, until November 22, 1990, and 3 Swiss cities (SKIPOGH), from November 25, 2009, through April 4, 2013. We measured plasma concentrations (FLEMENGHO, SKIPOGH) and 24-hour urinary excretions (SKIPOGH) of 4 methylxanthines—caffeine, paraxanthine, theobromine, and theophylline—using ultra-high-performance liquid chromatography–tandem mass spectrometry. We used enzymatic methods to estimate total cholesterol, high-density lipoprotein cholesterol, and triglyceride levels and the Friedewald equation for low-density lipoprotein cholesterol levels in plasma. We applied sex-specific mixed models to investigate associations between methylxanthines and plasma lipids, adjusting for major confounders.
In both FLEMENGHO (N=1987; 1055 [53%] female participants) and SKIPOGH (N=990; 523 [53%] female participants), total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels increased across quartiles of plasma caffeine, paraxanthine, and theophylline (total cholesterol levels by caffeine quartiles in FLEMENGHO, male participants: 5.01±0.06 mmol/L, 5.05±0.06 mmol/L, 5.27±0.06 mmol/L, 5.62±0.06 mmol/L; female participants: 5.24±0.06 mmol/L, 5.15±0.05 mmol/L, 5.25±0.05 mmol/L, 5.42±0.05 mmol/L). Similar results were observed using urinary methylxanthines in SKIPOGH (total cholesterol levels by caffeine quartiles, male participants: 4.54±0.08 mmol/L, 4.94±0.08 mmol/L, 4.87±0.08 mmol/L, 5.27±0.09 mmol/L; female participants: 5.12±0.07 mmol/L, 5.21±0.07 mmol/L, 5.28±0.05 mmol/L, 5.28±0.07 mmol/L). Furthermore, urinary caffeine and theophylline were positively associated with high-density lipoprotein cholesterol in SKIPOGH male participants.
Plasma and urinary caffeine, paraxanthine, and theophylline were positively associated with plasma lipids, whereas the associations involving theobromine were less clear. We postulate that the positive association between caffeine intake and plasma lipids may be related to the sympathomimetic function of methylxanthines, mitigating the overall health-beneficial effect of caffeine intake. |
doi_str_mv | 10.1016/j.mayocp.2021.05.030 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_2577450159</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A689992344</galeid><els_id>S0025619621005516</els_id><sourcerecordid>A689992344</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-6be6b1b3f9a049ca992897ff5cdcb6c2f66a3c5711ec59214956189963d69a913</originalsourceid><addsrcrecordid>eNp9kUtv1DAUhS0EotPCP0DIK8QmwXZsZ7xBagcKlQZR8VhbjnMz41Fip7EzqP8eDykINsgLP_Sd43vvQegFJSUlVL45lIO5D3YsGWG0JKIkFXmEVlRxVgjB5WO0IoSJQlIlz9B5jAdCSK0Uf4rOKi5OJ7FC440_QkxuZ5LzO5z2gL9Any_BR3wF6QeAxxvTdeA8FO9gckdo8SdIpgm9SxCx8S2-7U0cDN660bURO48Zvg3jvPgUVyZmzdc0tw7iM_SkM32E5w_7Bfp-_f7b5mOx_fzhZnO5LSyv16mQDciGNlWnDOHKGqXYWtVdJ2xrG2lZJ6WprKgpBSsUo1wJSddKyaqVyihaXaDXi-84hbs5t6gHFy30vfEQ5qiZqGsuCBUqo-WC7kwP2vkupMnYvFoYnA0eOpffL2W2V6ziPAte_SXYg-nTPoZ-_jW1f0G-gHYKMU7Q6XFyg5nuNSX6lKI-6CVFfUpRE6Fziln28qH2uRmg_SP6HVsG3i4A5AkeHUw6WgfeQusmsEm3wf3_h5_pzK8-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2577450159</pqid></control><display><type>article</type><title>Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Petrovic, Dusan ; Pruijm, Menno ; Ponte, Belén ; Dhayat, Nasser A. ; Ackermann, Daniel ; Ehret, Georg ; Ansermot, Nicolas ; Vogt, Bruno ; Martin, Pierre-Yves ; Stringhini, Silvia ; Estoppey-Younès, Sandrine ; Thijs, Lutgarde ; Zhang, Zhenyu ; Melgarejo, Jesus D. ; Eap, Chin B. ; Staessen, Jan A. ; Bochud, Murielle ; Guessous, Idris</creator><creatorcontrib>Petrovic, Dusan ; Pruijm, Menno ; Ponte, Belén ; Dhayat, Nasser A. ; Ackermann, Daniel ; Ehret, Georg ; Ansermot, Nicolas ; Vogt, Bruno ; Martin, Pierre-Yves ; Stringhini, Silvia ; Estoppey-Younès, Sandrine ; Thijs, Lutgarde ; Zhang, Zhenyu ; Melgarejo, Jesus D. ; Eap, Chin B. ; Staessen, Jan A. ; Bochud, Murielle ; Guessous, Idris</creatorcontrib><description>To investigate the relations between caffeine-derived metabolites (methylxanthines) and plasma lipids by use of population-based data from 2 European countries.
Families were randomly selected from the general population of northern Belgium (FLEMENGHO), from August 12, 1985, until November 22, 1990, and 3 Swiss cities (SKIPOGH), from November 25, 2009, through April 4, 2013. We measured plasma concentrations (FLEMENGHO, SKIPOGH) and 24-hour urinary excretions (SKIPOGH) of 4 methylxanthines—caffeine, paraxanthine, theobromine, and theophylline—using ultra-high-performance liquid chromatography–tandem mass spectrometry. We used enzymatic methods to estimate total cholesterol, high-density lipoprotein cholesterol, and triglyceride levels and the Friedewald equation for low-density lipoprotein cholesterol levels in plasma. We applied sex-specific mixed models to investigate associations between methylxanthines and plasma lipids, adjusting for major confounders.
In both FLEMENGHO (N=1987; 1055 [53%] female participants) and SKIPOGH (N=990; 523 [53%] female participants), total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels increased across quartiles of plasma caffeine, paraxanthine, and theophylline (total cholesterol levels by caffeine quartiles in FLEMENGHO, male participants: 5.01±0.06 mmol/L, 5.05±0.06 mmol/L, 5.27±0.06 mmol/L, 5.62±0.06 mmol/L; female participants: 5.24±0.06 mmol/L, 5.15±0.05 mmol/L, 5.25±0.05 mmol/L, 5.42±0.05 mmol/L). Similar results were observed using urinary methylxanthines in SKIPOGH (total cholesterol levels by caffeine quartiles, male participants: 4.54±0.08 mmol/L, 4.94±0.08 mmol/L, 4.87±0.08 mmol/L, 5.27±0.09 mmol/L; female participants: 5.12±0.07 mmol/L, 5.21±0.07 mmol/L, 5.28±0.05 mmol/L, 5.28±0.07 mmol/L). Furthermore, urinary caffeine and theophylline were positively associated with high-density lipoprotein cholesterol in SKIPOGH male participants.
Plasma and urinary caffeine, paraxanthine, and theophylline were positively associated with plasma lipids, whereas the associations involving theobromine were less clear. We postulate that the positive association between caffeine intake and plasma lipids may be related to the sympathomimetic function of methylxanthines, mitigating the overall health-beneficial effect of caffeine intake.</description><identifier>ISSN: 0025-6196</identifier><identifier>EISSN: 1942-5546</identifier><identifier>DOI: 10.1016/j.mayocp.2021.05.030</identifier><identifier>PMID: 34579945</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Adult ; Belgium ; Caffeine ; Caffeine - adverse effects ; Caffeine - blood ; Caffeine - metabolism ; Caffeine - urine ; Cholesterol - blood ; Cholesterol, HDL - blood ; Chromatography, High Pressure Liquid ; Complications and side effects ; Coronary heart disease ; Dyslipidemias ; Female ; Health aspects ; Humans ; Lipids - blood ; Male ; Metabolites ; Middle Aged ; Risk factors ; Switzerland ; Tandem Mass Spectrometry ; Theobromine - adverse effects ; Theobromine - blood ; Theobromine - urine ; Theophylline - adverse effects ; Theophylline - blood ; Theophylline - urine ; Triglycerides - blood ; Xanthines - adverse effects ; Xanthines - blood ; Xanthines - urine</subject><ispartof>Mayo Clinic proceedings, 2021-12, Vol.96 (12), p.3071-3085</ispartof><rights>2021 Mayo Foundation for Medical Education and Research</rights><rights>Copyright © 2021 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights reserved.</rights><rights>COPYRIGHT 2021 Elsevier, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-6be6b1b3f9a049ca992897ff5cdcb6c2f66a3c5711ec59214956189963d69a913</citedby><cites>FETCH-LOGICAL-c478t-6be6b1b3f9a049ca992897ff5cdcb6c2f66a3c5711ec59214956189963d69a913</cites><orcidid>0000-0003-4730-6050 ; 0000-0003-3684-4582</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34579945$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Petrovic, Dusan</creatorcontrib><creatorcontrib>Pruijm, Menno</creatorcontrib><creatorcontrib>Ponte, Belén</creatorcontrib><creatorcontrib>Dhayat, Nasser A.</creatorcontrib><creatorcontrib>Ackermann, Daniel</creatorcontrib><creatorcontrib>Ehret, Georg</creatorcontrib><creatorcontrib>Ansermot, Nicolas</creatorcontrib><creatorcontrib>Vogt, Bruno</creatorcontrib><creatorcontrib>Martin, Pierre-Yves</creatorcontrib><creatorcontrib>Stringhini, Silvia</creatorcontrib><creatorcontrib>Estoppey-Younès, Sandrine</creatorcontrib><creatorcontrib>Thijs, Lutgarde</creatorcontrib><creatorcontrib>Zhang, Zhenyu</creatorcontrib><creatorcontrib>Melgarejo, Jesus D.</creatorcontrib><creatorcontrib>Eap, Chin B.</creatorcontrib><creatorcontrib>Staessen, Jan A.</creatorcontrib><creatorcontrib>Bochud, Murielle</creatorcontrib><creatorcontrib>Guessous, Idris</creatorcontrib><title>Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies</title><title>Mayo Clinic proceedings</title><addtitle>Mayo Clin Proc</addtitle><description>To investigate the relations between caffeine-derived metabolites (methylxanthines) and plasma lipids by use of population-based data from 2 European countries.
Families were randomly selected from the general population of northern Belgium (FLEMENGHO), from August 12, 1985, until November 22, 1990, and 3 Swiss cities (SKIPOGH), from November 25, 2009, through April 4, 2013. We measured plasma concentrations (FLEMENGHO, SKIPOGH) and 24-hour urinary excretions (SKIPOGH) of 4 methylxanthines—caffeine, paraxanthine, theobromine, and theophylline—using ultra-high-performance liquid chromatography–tandem mass spectrometry. We used enzymatic methods to estimate total cholesterol, high-density lipoprotein cholesterol, and triglyceride levels and the Friedewald equation for low-density lipoprotein cholesterol levels in plasma. We applied sex-specific mixed models to investigate associations between methylxanthines and plasma lipids, adjusting for major confounders.
In both FLEMENGHO (N=1987; 1055 [53%] female participants) and SKIPOGH (N=990; 523 [53%] female participants), total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels increased across quartiles of plasma caffeine, paraxanthine, and theophylline (total cholesterol levels by caffeine quartiles in FLEMENGHO, male participants: 5.01±0.06 mmol/L, 5.05±0.06 mmol/L, 5.27±0.06 mmol/L, 5.62±0.06 mmol/L; female participants: 5.24±0.06 mmol/L, 5.15±0.05 mmol/L, 5.25±0.05 mmol/L, 5.42±0.05 mmol/L). Similar results were observed using urinary methylxanthines in SKIPOGH (total cholesterol levels by caffeine quartiles, male participants: 4.54±0.08 mmol/L, 4.94±0.08 mmol/L, 4.87±0.08 mmol/L, 5.27±0.09 mmol/L; female participants: 5.12±0.07 mmol/L, 5.21±0.07 mmol/L, 5.28±0.05 mmol/L, 5.28±0.07 mmol/L). Furthermore, urinary caffeine and theophylline were positively associated with high-density lipoprotein cholesterol in SKIPOGH male participants.
Plasma and urinary caffeine, paraxanthine, and theophylline were positively associated with plasma lipids, whereas the associations involving theobromine were less clear. We postulate that the positive association between caffeine intake and plasma lipids may be related to the sympathomimetic function of methylxanthines, mitigating the overall health-beneficial effect of caffeine intake.</description><subject>Adult</subject><subject>Belgium</subject><subject>Caffeine</subject><subject>Caffeine - adverse effects</subject><subject>Caffeine - blood</subject><subject>Caffeine - metabolism</subject><subject>Caffeine - urine</subject><subject>Cholesterol - blood</subject><subject>Cholesterol, HDL - blood</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Complications and side effects</subject><subject>Coronary heart disease</subject><subject>Dyslipidemias</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Lipids - blood</subject><subject>Male</subject><subject>Metabolites</subject><subject>Middle Aged</subject><subject>Risk factors</subject><subject>Switzerland</subject><subject>Tandem Mass Spectrometry</subject><subject>Theobromine - adverse effects</subject><subject>Theobromine - blood</subject><subject>Theobromine - urine</subject><subject>Theophylline - adverse effects</subject><subject>Theophylline - blood</subject><subject>Theophylline - urine</subject><subject>Triglycerides - blood</subject><subject>Xanthines - adverse effects</subject><subject>Xanthines - blood</subject><subject>Xanthines - urine</subject><issn>0025-6196</issn><issn>1942-5546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtv1DAUhS0EotPCP0DIK8QmwXZsZ7xBagcKlQZR8VhbjnMz41Fip7EzqP8eDykINsgLP_Sd43vvQegFJSUlVL45lIO5D3YsGWG0JKIkFXmEVlRxVgjB5WO0IoSJQlIlz9B5jAdCSK0Uf4rOKi5OJ7FC440_QkxuZ5LzO5z2gL9Any_BR3wF6QeAxxvTdeA8FO9gckdo8SdIpgm9SxCx8S2-7U0cDN660bURO48Zvg3jvPgUVyZmzdc0tw7iM_SkM32E5w_7Bfp-_f7b5mOx_fzhZnO5LSyv16mQDciGNlWnDOHKGqXYWtVdJ2xrG2lZJ6WprKgpBSsUo1wJSddKyaqVyihaXaDXi-84hbs5t6gHFy30vfEQ5qiZqGsuCBUqo-WC7kwP2vkupMnYvFoYnA0eOpffL2W2V6ziPAte_SXYg-nTPoZ-_jW1f0G-gHYKMU7Q6XFyg5nuNSX6lKI-6CVFfUpRE6Fziln28qH2uRmg_SP6HVsG3i4A5AkeHUw6WgfeQusmsEm3wf3_h5_pzK8-</recordid><startdate>202112</startdate><enddate>202112</enddate><creator>Petrovic, Dusan</creator><creator>Pruijm, Menno</creator><creator>Ponte, Belén</creator><creator>Dhayat, Nasser A.</creator><creator>Ackermann, Daniel</creator><creator>Ehret, Georg</creator><creator>Ansermot, Nicolas</creator><creator>Vogt, Bruno</creator><creator>Martin, Pierre-Yves</creator><creator>Stringhini, Silvia</creator><creator>Estoppey-Younès, Sandrine</creator><creator>Thijs, Lutgarde</creator><creator>Zhang, Zhenyu</creator><creator>Melgarejo, Jesus D.</creator><creator>Eap, Chin B.</creator><creator>Staessen, Jan A.</creator><creator>Bochud, Murielle</creator><creator>Guessous, Idris</creator><general>Elsevier Inc</general><general>Elsevier, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4730-6050</orcidid><orcidid>https://orcid.org/0000-0003-3684-4582</orcidid></search><sort><creationdate>202112</creationdate><title>Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies</title><author>Petrovic, Dusan ; Pruijm, Menno ; Ponte, Belén ; Dhayat, Nasser A. ; Ackermann, Daniel ; Ehret, Georg ; Ansermot, Nicolas ; Vogt, Bruno ; Martin, Pierre-Yves ; Stringhini, Silvia ; Estoppey-Younès, Sandrine ; Thijs, Lutgarde ; Zhang, Zhenyu ; Melgarejo, Jesus D. ; Eap, Chin B. ; Staessen, Jan A. ; Bochud, Murielle ; Guessous, Idris</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-6be6b1b3f9a049ca992897ff5cdcb6c2f66a3c5711ec59214956189963d69a913</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Belgium</topic><topic>Caffeine</topic><topic>Caffeine - adverse effects</topic><topic>Caffeine - blood</topic><topic>Caffeine - metabolism</topic><topic>Caffeine - urine</topic><topic>Cholesterol - blood</topic><topic>Cholesterol, HDL - blood</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Complications and side effects</topic><topic>Coronary heart disease</topic><topic>Dyslipidemias</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Lipids - blood</topic><topic>Male</topic><topic>Metabolites</topic><topic>Middle Aged</topic><topic>Risk factors</topic><topic>Switzerland</topic><topic>Tandem Mass Spectrometry</topic><topic>Theobromine - adverse effects</topic><topic>Theobromine - blood</topic><topic>Theobromine - urine</topic><topic>Theophylline - adverse effects</topic><topic>Theophylline - blood</topic><topic>Theophylline - urine</topic><topic>Triglycerides - blood</topic><topic>Xanthines - adverse effects</topic><topic>Xanthines - blood</topic><topic>Xanthines - urine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Petrovic, Dusan</creatorcontrib><creatorcontrib>Pruijm, Menno</creatorcontrib><creatorcontrib>Ponte, Belén</creatorcontrib><creatorcontrib>Dhayat, Nasser A.</creatorcontrib><creatorcontrib>Ackermann, Daniel</creatorcontrib><creatorcontrib>Ehret, Georg</creatorcontrib><creatorcontrib>Ansermot, Nicolas</creatorcontrib><creatorcontrib>Vogt, Bruno</creatorcontrib><creatorcontrib>Martin, Pierre-Yves</creatorcontrib><creatorcontrib>Stringhini, Silvia</creatorcontrib><creatorcontrib>Estoppey-Younès, Sandrine</creatorcontrib><creatorcontrib>Thijs, Lutgarde</creatorcontrib><creatorcontrib>Zhang, Zhenyu</creatorcontrib><creatorcontrib>Melgarejo, Jesus D.</creatorcontrib><creatorcontrib>Eap, Chin B.</creatorcontrib><creatorcontrib>Staessen, Jan A.</creatorcontrib><creatorcontrib>Bochud, Murielle</creatorcontrib><creatorcontrib>Guessous, Idris</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Mayo Clinic proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Petrovic, Dusan</au><au>Pruijm, Menno</au><au>Ponte, Belén</au><au>Dhayat, Nasser A.</au><au>Ackermann, Daniel</au><au>Ehret, Georg</au><au>Ansermot, Nicolas</au><au>Vogt, Bruno</au><au>Martin, Pierre-Yves</au><au>Stringhini, Silvia</au><au>Estoppey-Younès, Sandrine</au><au>Thijs, Lutgarde</au><au>Zhang, Zhenyu</au><au>Melgarejo, Jesus D.</au><au>Eap, Chin B.</au><au>Staessen, Jan A.</au><au>Bochud, Murielle</au><au>Guessous, Idris</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies</atitle><jtitle>Mayo Clinic proceedings</jtitle><addtitle>Mayo Clin Proc</addtitle><date>2021-12</date><risdate>2021</risdate><volume>96</volume><issue>12</issue><spage>3071</spage><epage>3085</epage><pages>3071-3085</pages><issn>0025-6196</issn><eissn>1942-5546</eissn><abstract>To investigate the relations between caffeine-derived metabolites (methylxanthines) and plasma lipids by use of population-based data from 2 European countries.
Families were randomly selected from the general population of northern Belgium (FLEMENGHO), from August 12, 1985, until November 22, 1990, and 3 Swiss cities (SKIPOGH), from November 25, 2009, through April 4, 2013. We measured plasma concentrations (FLEMENGHO, SKIPOGH) and 24-hour urinary excretions (SKIPOGH) of 4 methylxanthines—caffeine, paraxanthine, theobromine, and theophylline—using ultra-high-performance liquid chromatography–tandem mass spectrometry. We used enzymatic methods to estimate total cholesterol, high-density lipoprotein cholesterol, and triglyceride levels and the Friedewald equation for low-density lipoprotein cholesterol levels in plasma. We applied sex-specific mixed models to investigate associations between methylxanthines and plasma lipids, adjusting for major confounders.
In both FLEMENGHO (N=1987; 1055 [53%] female participants) and SKIPOGH (N=990; 523 [53%] female participants), total cholesterol, low-density lipoprotein cholesterol, and triglyceride levels increased across quartiles of plasma caffeine, paraxanthine, and theophylline (total cholesterol levels by caffeine quartiles in FLEMENGHO, male participants: 5.01±0.06 mmol/L, 5.05±0.06 mmol/L, 5.27±0.06 mmol/L, 5.62±0.06 mmol/L; female participants: 5.24±0.06 mmol/L, 5.15±0.05 mmol/L, 5.25±0.05 mmol/L, 5.42±0.05 mmol/L). Similar results were observed using urinary methylxanthines in SKIPOGH (total cholesterol levels by caffeine quartiles, male participants: 4.54±0.08 mmol/L, 4.94±0.08 mmol/L, 4.87±0.08 mmol/L, 5.27±0.09 mmol/L; female participants: 5.12±0.07 mmol/L, 5.21±0.07 mmol/L, 5.28±0.05 mmol/L, 5.28±0.07 mmol/L). Furthermore, urinary caffeine and theophylline were positively associated with high-density lipoprotein cholesterol in SKIPOGH male participants.
Plasma and urinary caffeine, paraxanthine, and theophylline were positively associated with plasma lipids, whereas the associations involving theobromine were less clear. We postulate that the positive association between caffeine intake and plasma lipids may be related to the sympathomimetic function of methylxanthines, mitigating the overall health-beneficial effect of caffeine intake.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>34579945</pmid><doi>10.1016/j.mayocp.2021.05.030</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0003-4730-6050</orcidid><orcidid>https://orcid.org/0000-0003-3684-4582</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0025-6196 |
ispartof | Mayo Clinic proceedings, 2021-12, Vol.96 (12), p.3071-3085 |
issn | 0025-6196 1942-5546 |
language | eng |
recordid | cdi_proquest_miscellaneous_2577450159 |
source | MEDLINE; Alma/SFX Local Collection |
subjects | Adult Belgium Caffeine Caffeine - adverse effects Caffeine - blood Caffeine - metabolism Caffeine - urine Cholesterol - blood Cholesterol, HDL - blood Chromatography, High Pressure Liquid Complications and side effects Coronary heart disease Dyslipidemias Female Health aspects Humans Lipids - blood Male Metabolites Middle Aged Risk factors Switzerland Tandem Mass Spectrometry Theobromine - adverse effects Theobromine - blood Theobromine - urine Theophylline - adverse effects Theophylline - blood Theophylline - urine Triglycerides - blood Xanthines - adverse effects Xanthines - blood Xanthines - urine |
title | Investigating the Relations Between Caffeine-Derived Metabolites and Plasma Lipids in 2 Population-Based Studies |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T20%3A33%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Investigating%20the%20Relations%20Between%20Caffeine-Derived%20Metabolites%20and%20Plasma%20Lipids%20in%202%20Population-Based%20Studies&rft.jtitle=Mayo%20Clinic%20proceedings&rft.au=Petrovic,%20Dusan&rft.date=2021-12&rft.volume=96&rft.issue=12&rft.spage=3071&rft.epage=3085&rft.pages=3071-3085&rft.issn=0025-6196&rft.eissn=1942-5546&rft_id=info:doi/10.1016/j.mayocp.2021.05.030&rft_dat=%3Cgale_proqu%3EA689992344%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2577450159&rft_id=info:pmid/34579945&rft_galeid=A689992344&rft_els_id=S0025619621005516&rfr_iscdi=true |